Identification of Biorelevant Dissolution Media to Assess Biopharmaceutical Performance of Erlotinib Formulation With Enhanced Bioavailability Using Physiologybased Pharmacokinetic Modeling. AJP 2022, 16 (2). https://doi.org/10.22377/ajp.v16i2.4389.